The DOI matches its Crossref record.
Healing of large segmental defects in rat femurs is aided by RhBMP‐2 in PLGA matrix
Abstract
Recombinant human bone morphogenetic protein‐ (rhBMP‐) can be used to enhance the repair of congenital or acquired bone pathologies when formulated in the appropriate carrier. Poly [D, L‐(lactide‐co‐glycolide)] (PLGA) has been shown to be an effective carrier of rhBMP‐. We investigated several particle sizes PLGA and several doses of rhBMP‐ in a rat orthotopic model. We also investigated the effects of a fibrinolytic inhibitory agent, epsilon aminocaproic acid (EACA), on the healing response. Our data indicate that higher doses of rhBMP‐ resulted in increased failure torque (408 ± 70 N‐mm or 60% of the intact value) and higher incidence of union (100%). The induced bone in femurs treated with the smaller particle size PLGA achieved the greatest torsional stiffness and strength. The presence of rhBMP‐ was necessary for new bone to form, but the presence of EACA did not change these results; the use of the PLGA carrier appeared to increase bone strength and stiffness. In fact, with higher doses of rhBMP‐ in PLGA, the stiffness of the new bone was equal to that of intact controls (64 ± 20 N‐mm/deg [intact femurs] versus 45 ± 10 N‐mm/degree [medium dose in small PLGA], 61 ± 17 N‐mm/degree [high dose in small PLGA], and 36 ± 11 N‐mm/degree [medium dose in large PLGA]; P > .05). In conclusion, PLGA implanted with rhBMP‐ effectively aided in healing large segmental defects in rat femurs. © 1994 John Wiley & Sons, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Biomaterials in Tissue Engineering
Hubbell, J. A. (1995) · Nature Biotechnology · doi:10.1038/nbt0695-565 · Cited by 1,060
OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)
CHENG, H., JIANG, W., PHILLIPS, F. M., HAYDON, R. C., PENG, Y., ZHOU, L., LUU, H. H., AN, N., BREYER, B., VANICHAKARN, P., et al. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200308000-00017 · Cited by 1,012
Functionalized silk-based biomaterials for bone formation
Sofia, S., McCarthy, M. B., Gronowicz, G., & Kaplan, D. L. (2001) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(200101)54:1<139::aid-jbm17>3.0.co;2-7 · Cited by 819
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.004 · Cited by 814
Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells
Bruder, S. P., Kurth, A. A., Shea, M., Hayes, W. C., Jaiswal, N., & Kadiyala, S. (1998) · Journal of Orthopaedic Research · doi:10.1002/jor.1100160202 · Cited by 761
Self-citationEvolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone
Yaszemski, M. J., Payne, R. G., Hayes, W. C., Langer, R., & Mikos, A. G. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85762-0 · Cited by 729
Self-citationToward delivery of multiple growth factors in tissue engineering
Chen, F.-M., Zhang, M., & Wu, Z.-F. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.053 · Cited by 649
Host response to tissue engineered devices
Babensee, J. E., Anderson, J. M., McIntire, L. V., & Mikos, A. G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00023-4 · Cited by 585
Kang, Q., Sun, M. H., Cheng, H., Peng, Y., Montag, A. G., Deyrup, A. T., Jiang, W., Luu, H. H., Luo, J., Szatkowski, J. P., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302298 · Cited by 575
Zara, J. N., Siu, R. K., Zhang, X., Shen, J., Ngo, R., Lee, M., Li, W., Chiang, M., Chung, J., Kwak, J., et al. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0555 · Cited by 560
Bessa, P. C., Casal, M., & Reis, R. L. (2008) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.74 · Cited by 549
Growth Factor Delivery for Tissue Engineering
Babensee, J. E., McIntire, L. V., & Mikos, A. G. (2000) · Pharmaceutical Research · doi:10.1023/a:1007502828372 · Cited by 435
Bone morphogenetic proteins in human bone regeneration
Groeneveld, E., & Burger, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420009 · Cited by 404
Immune modulation by mesenchymal stem cells
Rasmusson, I. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.019 · Cited by 374
Crane, G. M., Ishaug, S. L., & Mikos, A. G. (1995) · Nature Medicine · doi:10.1038/nm1295-1322 · Cited by 348
Delivering on the promise of bone morphogenetic proteins
Li, R. H., & Wozney, J. M. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(01)01665-1 · Cited by 339
Potential applications and delivery strategies for bone morphogenetic proteins
Kirker-Head, C. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00078-8 · Cited by 294
The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres
Wei, G., Jin, Q., Giannobile, W. V., & Ma, P. X. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.028 · Cited by 292
Cell-free and cell-based approaches for bone regeneration
Bueno, E. M., & Glowacki, J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.228 · Cited by 279
Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration
El Bialy, I., Jiskoot, W., & Reza Nejadnik, M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2147-x · Cited by 257
New synthetic biodegradable polymers as BMP carriers for bone tissue engineering
Saito, N., & Takaoka, K. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00040-1 · Cited by 153
Metadata
- Authors
- Lee, S. C., Shea, M., Battle, M. A., Kozitza, K., Ron, E., Turek, T., Schaub, R. G., & Hayes, W. C.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 1994-10
- Volume
- 28
- Issue
- 10
- Pages
- 1149-1156
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W2170641637
- Cited by
- 167
- References
- 0
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.